Platelets govern pre-metastatic tumor communication to bone

Oncogene

Volumn 32, Issue 36, 2013, Pages 4319-4324

  Kerr, B A ^a   Mccabe, N P ^a,d   Feng, W ^a,b   Byzova, T V ^a,c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b XI'AN JIAOTONG UNIVERSITY   (China)

^c TAUSSIG CANCER INSTITUTE   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

bone metastasis; bone remodeling; platelet; tumor

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; COLLAGENASE 3; INTERSTITIAL COLLAGENASE; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE METABOLISM; BONE METASTASIS; BONE MINERALIZATION; BONE REMODELING; BONE STRUCTURE; BONE TURNOVER; CANCER TRANSPLANTATION; CONTROLLED STUDY; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLASTOGENESIS; PRIMARY TUMOR; PRIORITY JOURNAL; PROSTATE CANCER; THROMBOCYTE; THROMBOCYTE ACTIVATION; TUMOR GROWTH;

ALKALINE PHOSPHATASE; ANIMALS; BLOOD PLATELETS; BONE AND BONES; BONE NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; HUMANS; MALE; MATRIX METALLOPROTEINASES; MICE; NEOPLASMS; OSTEOCALCIN; OSTEOGENESIS; TRANSFORMING GROWTH FACTOR BETA1; TRANSPLANTATION, HETEROLOGOUS;

EID: 84883741996     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.447     Document Type: Article

References (42)

1. American Cancer Society. Prostate Cancer. American Cancer Society: Atlanta, GA, 2008.
2. American Cancer Society. Melanoma Skin Cancer. American Cancer Society: Atlanta, GA, 2008.
3. Coleman RE, Guise TA, Lipton A, Roodman GD, Berenson JR, Body J-J et al. Advancing Treatment for Metastatic Bone Cancer. Clin Cancer Res 2008; 14: 6387-6395.
4. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61: 212-236.
5. Kingsley LA, Fournier PGJ, Chirgwin JM, Guise TA. Molecular Biology of Bone Metastasis. Mol Cancer Ther 2007; 6: 2609-2617.
6. Mundy GR. Metastasis to Bone: Causes Consequences and Therapeutic Opportunities. Nat Rev Cancer 2002; 2: 584-593.
7. Karpatkin S, Pearlstein E, Ambrogio C, Coller BS. Role of Adhesive Proteins in Platelet Tumor Interaction In Vitro and Metastasis Formation In Vivo. J Clin Invest 1988; 81: 1012-1019.
8. Borsig L. The Role of Platelet Activation in Tumor Metastasis. Expert Rev Anticancer Ther 2008; 8: 1247-1255.
9. Feng W, Madajka M, Kerr BA, Mahabeleshwar GH, Whiteheart SW, Byzova TV. A novel role for platelet secretion in angiogenesis: mediating bone marrowderived cell mobilization and homing. Blood 2011; 117: 3893-3902.
10. Kawasumi M, Kitoh H, Siwicka KA, Ishiguro N. The Effect of the Platelet Concentration in Platelet-Rich Plasma Gel on the Regeneration of Bone. J Bone Joint Surg Br 2007; 90-B: 966-972.
11. Uggeri J, Belletti S, Guizzardi S, Poli T, Cantarelli S, Scandroglio R et al. Dose-Dependent Effects of Platelet Gel Releasate on Activites of Human Osteoblasts. J Periodontol 2007; 78: 1985-1991.
12. Gruber R, Karreth F, Fischer MB, Watzek G. Platelet-Released Supernatants Stimulate Formation of Osteoclast-like Cells through a Prostaglandin/ RANKLDependent Mechanism. Bone 2002; 30: 726-732.
13. Nair MB, Varma HK, John A. Platelet-Rich Plasma and Fibrin Glue-Coated Bioactive Ceramics Enhance Growth and Differentiation of Goat Bone Marrow-Derived Stem Cells. Tissue Eng Part A 2009; 15: 1619-1631.
14. McCabe NP, Madajka M, Vasanji A, Byzova TV. Intraosseous Injection of RM1 Murine Prostate Cancer Cells Promotes Rapid Osteolysis and Periosteal Bone Deposition. Clin Exp Metastasis 2008; 25: 581-590.
15. McCabe NP, De S, Vasanji A, Brainard J, Byzova TV. Prostate Cancer Specific Integrin avb3 Modulates Bone Metastatic Growth and Tissue Remodeling. Oncogene 2007; 26: 6238-6243.
16. McCabe NP, Kerr BA, Madajka M, Vasanji A, Byzova TV. Augmented Osteolysis in SPARC-Deficient Mice with Bone-Residing Prostate Cancer. Neoplasia 2011; 13: 31-39.
17. Gomes Jr RR, Buttke P, Paul EM, Sikes RA. Osteosclerotic prostate cancer metastasis to murine bone are enhanced with increased bone formation. Clin Exp Metastasis 2009; 26: 641-651.
18. Edlund M, Sung S-Y, Chung LW. Modulation of Prostate Cancer Growth in Bone Microenvironments. J Cell Biochem 2004; 91: 686-705.
19. Roudier MP, Morrissey C, True LD, Higano CS, Vessella RL, Ott SM. Histopathological Assessment of Prostate Cancer Bone Osteoblastic Metastases. J Urol 2008; 180: 1154-1160.
20. Feng W, McCabe NP, Mahabeleshwar GH, Somanath PR, Phillips DR, Byzova TV. The Angiogenic Response Is Dictated by b3 Integrin on Bone Marrow-Derived Cells. J Cell Biol 2008; 183: 1145-1157.
21. Rhee JS, Black M, Schubert U, Fischer S, Morgenstern E, Hammes HP et al. The functional role of blood platelet components in angiogenesis. Thromb Haemost 2004; 92: 394-402.
22. Gasic GJ, Gasic TB, Stewart CC. Antimetastatic Effects Associated with Platelet Reduction. Proc Natl Acad Sci USA 1968; 61: 46-52.
23. Borsig L, Wong R, Feramisco J, Nadeau DR, Varki NM, Varki A. Heparin and Cancer Revisited: Mechanistic Connections Involving Platelets, P-selectin, Carcinoma Mucins, and Tumor Metastasis. Proc Natl Acad Sci USA 2001; 98: 3352-3357.
24. Oprea WE, Karp JM, Hosseini MM, Davies JE. Effect of platelet releasate on bone cell migration and recruitment in vitro. J Craniofac Surg 2003; 14: 292-300.
25. Mishra A, Tummala P, King A, Lee B, Kraus M, Tse V et al. Buffered platelet-rich plasma enhances mesenchymal stem cell proliferation and chondrogenic differentiation. Tissue Eng Part C Methods 2009; 15: 431-435.
26. Italiano Jr JE, Richardson JL, Patel-Hett S, Battinelli E, Zaslavsky A, Short S et al. Angiogenesis Is Regulated by a Novel Mechanism: Pro-and Antiangiogenic Proteins Are Organized into Separate Platelet a Granules and Differentially Released. Blood, 2008; 111: 1227-1233.
27. Klement GL, Yip T-T, Cassiola F, Kikuchi L, Cervi D, Podust VN et al. Platelets Actively Sequester Angiogenesis Regulators. Blood 2009; 113: 2835-2842.
28. Baselga J, Rothenberg ML, Tabernero J, Seoane J, Daly T, Cleverly A et al. TGF-b Signalling-Related Markers in Cancer Patients with Bone Metastasis. Biomarkers 2008; 13: 217-236.
29. Shariat SF, Shalev M, Menesses-Diaz A, Kim IY, Kattan MW, Wheeler TM et al. Preoperative Plasma Levels of Transforming Growth Factor Beta1 (TGF-b1) Strongly Predict Progression in Patients Undergoing Radical Prostatectomy. J Clin Oncol 2001; 19: 2856-2864.
30. Stellos K, Gawaz M. Platelet Interaction with Progenitor Cells: Potential Implications for Regenerative Medicine. Thromb Haemost 2007; 98: 922-929.
31. Schultz-Cherry S, Murphy-Ullrich JE. Thrombospondin Causes Activation of Latent Transforming Growth Factor-b Secreted by Endothelial Cells by a Novel Mechanism. J Cell Biol 1993; 122: 923-932.
32. Street J, Bao M, deGuzman L, Bunting S, Peale Jr FV, Ferrara N et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 2002; 99: 9656-9661.
33. Joyce ME, Roberts AB, Sporn MB, Bolander ME. Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur. J Cell Biol 1990; 110: 2195-2207.
34. Saadeh PB, Mehrara BJ, Steinbrech DS, Dudziak ME, Greenwald JA, Luchs JS et al. Transforming growth factor-beta1 modulates the expression of vascular endothelial growth factor by osteoblasts. Am J Physiol 1999; 277(4 Pt 1): C628-C637.
35. Zelzer E, McLean W, Ng YS, Fukai N, Reginato AM, Lovejoy S et al. Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis. Development 2002; 129: 1893-1904.
36. Sims NA, Gooi JH. Bone remodeling: Multiple cellular interactions required for coupling of bone formation and resorption. Semin Cell Dev Biol 2008; 19: 444-451.
37. Haeusler G, Walter I, Helmreich M, Egerbacher M. Localization of matrix metalloproteinases, (MMPs) their tissue inhibitors, and vascular endothelial growth factor (VEGF) in growth plates of children and adolescents indicates a role for MMPs in human postnatal growth and skeletal maturation. Calcif Tissue Int 2005; 76: 326-335.
38. Blouin S, Baslé MF, Chappard D. Interactions Between Microenvironment and Cancer Cells in Two Animal Models of Bone Metastasis. Br J Cancer 2008; 98: 809-815.
39. Jones DH, Nakashima T, Sanchez OH, Kozieradzki I, Komarova SV, Sarosi I et al. Regulation of Cancer Cell Migration and Bone Metastasis by RANKL. Nature 2006; 440: 692-696.
40. Kerr BA, Miocinovic R, Smith AK, Klein EA, Byzova TV. Comparison of Tumor and Microenvironment Secretomes in Plasma and in Platelets during Prostate Cancer Growth in a Xenograft Model. Neoplasia 2010; 12: 388-396.
41. Kerr BA, Byzova TV. MicroCT: An Essential Tool in Bone Metastasis Research. In: Saba L (ed). Computed Tomography-Clinical Applications. InTech, New York, USA, 2012, pp 211-230.
42. Reinholz GG, Getz B, Pederson L, Sanders ES, Subramaniam M, Ingle JN et al. Bisphosphonates Directly Regulate Cell Proliferation, Differentiation, and Gene Expression in Human Osteoblasts. Cancer Res 2000; 60: 6001-6007. Skin Diseases